If you’ve ever watched a patient bounce between “maybe it’s cellulitis” and “could it be osteomyelitis?” you know the diagnostic limbo I’m talking about. Infection doesn’t always read the textbook. That’s where nuclear medicine quietly saves the day.
Nuclear medicine isn’t about bigger magnets or sharper CT kernels. It’s about biology. We inject tiny amounts of radiotracers that go where the action is—glucose-hungry leukocytes, activated macrophages, inflamed endothelium—and then we capture the story with PET or SPECT cameras. It’s physiology meeting pixels.
So, what actually works?
FDG PET/CT (18F-FDG).
Think of FDG as a spotlight on inflammation. Cells revved up by infection burn glucose, FDG tags along, PET/CT maps it. The latest joint EANM/SNMMI guideline lays out where FDG shines—fever of unknown origin, vascular graft infection, vertebral osteomyelitis, and more. It’s not magic, but when you prep patients well and read patterns carefully, it’s a game-changer.
Radiolabeled white blood cell scans (WBC scintigraphy).
When you really need specificity—say, a painful prosthesis—you still can’t beat WBC scintigraphy with SPECT/CT. The workflow is old-school but powerful: draw blood, label the patient’s own leukocytes, reinject, image over time. It’s standardized and repeatable; see the EANM procedure guidance and the classic SNM practice guideline. In prosthetic joint infection, combining WBC with marrow imaging is still a heavy hitter.
Gallium-67—still has a role (selectively).
Not the first pick anymore, but for certain inflammatory or FUO scenarios, it can help. If you need a refresher, Radiopaedia’s Ga-67 overview and StatPearls review are solid, concise primers.
Where nuclear medicine really changes management
1) Musculoskeletal infection (MSK):
From osteomyelitis to spondylodiscitis to periprosthetic infection, biology-first imaging helps you answer the question that matters—is there active infection? FDG PET/CT is broadly sensitive; WBC is surgically specific. A recent open-access review walks through modality choices and pitfalls in MSK infection—worth a skim: Application of Nuclear Medicine in MSK Infection. For the day-to-day “is this PJI?” dilemma, see the Appropriate Use Criteria.
2) Diabetic foot infection:
Tricky, nuanced, time-sensitive. Imaging has to separate osteomyelitis from neuropathic change and map surgical extent. The EANM evidence-based guidance for the diabetic foot is practical; IDSA also links to the IWGDF pathway here.
3) Vascular graft/endograft infection:
This is where FDG PET/CT plus pattern-based interpretation earns its keep, especially when CT is equivocal. Bookmark the ESVS 2020 guideline PDF (endorsed by EANM) for workup and follow-up strategies.
4) FUO and “I think something’s smoldering”:
When the labs whisper but don’t shout, FDG PET/CT can survey the whole body once—lymph nodes, bones, heart valves, weird little abscesses hiding behind a clinical red herring. It’s not perfect, but it prevents a month of piecemeal tests.
Aren’t MRI and CT enough?
They’re fantastic—just different. MRI wins for marrow detail, soft tissue, and spine; CT is unbeatable for bone and hardware assessment. Nuclear imaging doesn’t replace them; it adds the biologic layer that answers “is this actually infected?” And when you fuse them (SPECT/CT, PET/CT), you get metabolism pinned to anatomy—no guessing which screw, which disc, which sinus tract.
PET/MRI? It’s coming along. The literature is still small, but growing—see Hybrid PET/MRI in Infection & Inflammation for an updated snapshot and where it may matter.
A quick reality check (because evidence matters)
No modality is infallible. FDG lights up sterile inflammation; WBC can be limited in spine; gallium is… gallium. That’s why guidelines emphasize protocols and context—patient prep, glucose control, acquisition timing, and pattern-based reads. If you build your algorithm around the EANM/SNMMI FDG guideline and WBC standards, your positive studies will change antibiotics, debridement plans, and OR timing—not just decorate the chart.
Antibiotic stewardship loves good imaging
The fastest way to fuel resistance is to treat the wrong thing, for too long. Clearer diagnoses support tighter courses. If you want a one-page reminder for teams and patients, the CDC’s resources are excellent here, and the WHO’s AMR snapshot is here.
Bottom line
When infection hides in plain sight, let biology lead. Use MRI/CT to map structure, then call in FDG PET/CT or WBC SPECT/CT to answer the “is it truly infected?” question with confidence. Faster diagnoses, smarter antibiotics, fewer surprises in the OR. That’s not fancy imaging—it’s better medicine.
Further reading (quick, reliable):
• EANM/SNMMI FDG in Infection & Inflammation v2.0 (2024): PDF
• WBC scintigraphy procedure/technique: PMC open access
• MSK infection overview (2024): PMC open access
• Appropriate Use Criteria—MSK infections (JNM): Link
• Vascular graft infection guidance (ESVS 2020): PDF
• PET/MRI review in infection/inflammation: PubMed
• Quick primers: Gallium-67 (Radiopaedia), MRI (Radiopaedia), CT (Radiopaedia)
• Stewardship resources: CDC Antibiotic Use, WHO AMR fact sheet
FDG PET/CT offers high sensitivity and whole-body survey; WBC adds specificity in suspected prosthetic joint infection or complex MSK cases. Many centers use FDG first, WBC when specificity is critical.
Not reliably by uptake alone. Pattern recognition, CT correlation, clinical context, and timing improve accuracy; WBC or marrow imaging can help when it’s equivocal.
Not entirely. It’s less used but can help in selected FUO/inflammatory scenarios or when WBC labeling isn’t feasible.
By localizing the source, defining extent, and confirming activity, imaging supports narrower agents, shorter courses, or escalation/debridement when needed.
Promising for spine and complex soft-tissue cases; evidence is growing, availability varies.
